8 citations
,
November 2022 in “Cureus” In this study, patients with mild to moderate scalp seborrheic dermatitis experienced greater improvements in severity scores and quality of life with Lulican™ shampoo compared to Ketoconazole over four weeks, with similar safety profiles but better tolerability and cosmetic acceptability for LulicanTM.
August 2023 in “Journal of Cosmetic Dermatology” This study found that intradermal QR678 Neo® therapy improved scalp condition in men and women with seborrheic dermatitis unresponsive to standard treatments, reducing flaking and inflammation after eight sessions, with high patient satisfaction reported.
14 citations
,
January 2020 in “Skin appendage disorders” This study found that a shampoo containing 0.075% broad-spectrum cannabidiol significantly reduced scalp inflammation and symptoms in subjects with mild to moderate scalp psoriasis or seborrheic dermatitis within two weeks.
June 2026 in “Frontiers in Allergy” In this study, patients with scalp seborrheic dermatitis exhibited distinct patterns of allergen sensitization tied to symptoms, impaired skin barrier, and altered microbiota, emphasizing the need to consider allergen exposure, barrier status, and microbial balance when interpreting patch test results.
June 2025 in “Indian Dermatology Online Journal” This study found that as the severity of androgenetic alopecia increased, the prevalence and severity of seborrheic dermatitis also increased.